[PDF][PDF] Genetics-informed precision treatment formulation in schizophrenia and bipolar disorder
Genetically informed drug development and repurposing is an attractive prospect for
improving patient outcomes in psychiatry; however, the effectiveness of these endeavors is …
improving patient outcomes in psychiatry; however, the effectiveness of these endeavors is …
Genetics-informed precision treatment formulation in schizophrenia and bipolar disorder
WR Reay, MP Geaghan, JR Atkins… - … journal of human …, 2022 - pubmed.ncbi.nlm.nih.gov
Genetically informed drug development and repurposing is an attractive prospect for
improving patient outcomes in psychiatry; however, the effectiveness of these endeavors is …
improving patient outcomes in psychiatry; however, the effectiveness of these endeavors is …
[HTML][HTML] Genetics-informed precision treatment formulation in schizophrenia and bipolar disorder
WR Reay, MP Geaghan, JR Atkins, VJ Carr… - American Journal of …, 2022 - ncbi.nlm.nih.gov
Genetically informed drug development and repurposing is an attractive prospect for
improving patient outcomes in psychiatry; however, the effectiveness of these endeavors is …
improving patient outcomes in psychiatry; however, the effectiveness of these endeavors is …
[HTML][HTML] Genetics-informed precision treatment formulation in schizophrenia and bipolar disorder
WR Reay, MP Geaghan, JR Atkins, VJ Carr… - The American Journal of …, 2022 - cell.com
Genetically informed drug development and repurposing is an attractive prospect for
improving patient outcomes in psychiatry; however, the effectiveness of these endeavors is …
improving patient outcomes in psychiatry; however, the effectiveness of these endeavors is …
[PDF][PDF] Genetics-informed precision treatment formulation in schizophrenia and bipolar disorder
WR Reay, MP Geaghan, JR Atkins… - … American Journal of …, 2022 - scienceopen.com
Genetically informed drug development and repurposing is an attractive prospect for
improving patient outcomes in psychiatry; however, the effectiveness of these endeavors is …
improving patient outcomes in psychiatry; however, the effectiveness of these endeavors is …
Genetics-informed precision treatment formulation in schizophrenia and bipolar disorder.
WR Reay, MP Geaghan, JR Atkins, VJ Carr… - American Journal of …, 2022 - europepmc.org
Genetically informed drug development and repurposing is an attractive prospect for
improving patient outcomes in psychiatry; however, the effectiveness of these endeavors is …
improving patient outcomes in psychiatry; however, the effectiveness of these endeavors is …
[HTML][HTML] Genetics-informed precision treatment formulation in schizophrenia and bipolar disorder
WR Reay, MP Geaghan, JR Atkins, VJ Carr… - The American Journal of …, 2022 - Elsevier
Genetically informed drug development and repurposing is an attractive prospect for
improving patient outcomes in psychiatry; however, the effectiveness of these endeavors is …
improving patient outcomes in psychiatry; however, the effectiveness of these endeavors is …
Genetics-informed precision treatment formulation in schizophrenia and bipolar disorder.
WR Reay, MP Geaghan, JR Atkins, VJ Carr… - American Journal of …, 2022 - europepmc.org
Genetically informed drug development and repurposing is an attractive prospect for
improving patient outcomes in psychiatry; however, the effectiveness of these endeavors is …
improving patient outcomes in psychiatry; however, the effectiveness of these endeavors is …